Returning to Normoglycemia With Targeted Use of Real-time CGM Data and Nutrition-focused Lifestyle Changes
Part of paid clinical trials in Bloomington, Minnesota.
- Sponsor
- HealthPartners Institute
- Study ID
- NCT07832474
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Prediabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- CGM-guided care — BEHAVIORALParticipants in the CGM arm use CGM data paired with a theory-informed behavioral intervention to guide personalized nutrition and lifestyle changes. The intervention aims to help CGM users make optimal use of their real-time and retrospective CGM data for the purposes of identifying and making behavior changes that reduce TA140. Participants in the CGM arm will receive support through three main components: 1) daily use of a real-time CGM system, 2) core CGM-guided lifestyle resources, and 3) personalized CGM-guided lifestyle education and support. The intervention focuses on food choices, physical activity, sleep, and stress reduction.
Study Details
The purpose of the ReTURN study is to understand how glycemia, specifically percent of time above 140 mg/dL (TA140), changes over time in people who are randomized to receive either continuous glucose monitoring (CGM)-guided care or usual care (UC) for 12 months. CGM-guided care includes daily use of a CGM system along with education and support. The hypothesis is that change in CGM-derived metrics from Baseline to Month 12 will show a larger improvement (reduction) in the CGM-Guided Lifestyle Change arm than the UC arm.
Key Dates
- First listed
- Sep 22, 2026
- Start date
- Oct 1, 2026
- Status verified
- Sep 2026
- Primary completion
- Dec 31, 2028
- Completion
- May 31, 2029
Study Design
- Enrollment
- 330 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: CGM-Guided Lifestyle CareThe CGM-guided care arm (the study intervention) includes three components 1) daily use of a real-time CGM system, 2) core CGM-guided lifestyle resources, and 3) personalized CGM-guided lifestyle education and support. The education and support is provided via one 60-minute in-person education and counseling session, six 30-minute virtual systematic CGM data review and lifestyle assessment sessions, and three asynchronous systematic CGM data review and lifestyle assessment messages sent via the electronic health record. The intervention content is provided by a registered dietitian nutritionist and focuses on using CGM data to help people optimize food choices, physical activity levels, sleep patterns, and stress management for improved prediabetes management.
- No Intervention: Usual Care (UC)Participants in the UC arm will receive generalized healthy lifestyle guidance and glycemic assessment (e.g. A1c, fasting glucose) at Baseline and at M12. Participants in the UC arm will also receive guidance for finding local diabetes prevention programs. The UC arm aligns with current practice for people with prediabetes.
Primary Outcome Measure
Change in CGM-derived % TA140 [ Time Frame: Baseline to 12 months ]
Central Contacts
- Holly Willis, PhD, RDN, CDCES952-993-3219
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| HealthPartners | Bloomington | Minnesota | 55425 |
Find similar trials in Bloomington, MN
Related Studies
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsRecruiting · Cleerly, Inc. · Chandler, Arizona
- Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Randomized Crossover TrialRecruiting · University of Minnesota · Lake Forest, Illinois
- Insulin and Insulin Pulses During FastingRecruiting · Mayo Clinic · Rochester, Minnesota
- Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 DiabetesRecruiting · Mayo Clinic · Rochester, Minnesota